Celularity (CELU) Current Assets (2018 - 2026)
Celularity's Current Assets was $6.45 million in Q2 2026, down 62.6% from $17.26 million a year earlier but up 2.3% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Celularity came in at $12.32 million, down 40.1% from FY2024.
- Current Assets shows a five-year compound annual growth rate of -29.8% (FY2020 to FY2025).
- In earlier years, Current Assets was $20.56 million in FY2024 (+3.9%), $19.79 million in FY2023 (-40.9%), $33.5 million in FY2022 (-43.3%) and $59.1 million in FY2021 (-18.1%).
- Quarterly Current Assets has moved between $6.3 million (Q1 2026) and $91.28 million (Q3 2021) over five years.
- Compared with a year earlier, Current Assets has declined for six straight quarters, with an average decline of 26.9% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q4 2024 (growth of 3.9%); the worst was Q2 2023 (a decline of 76.1%).
- Per Business Quant data, CELU's Current Assets in the three quarters before Q2 2026 was $6.3 million (Q1 2026), $12.32 million (Q4 2025) and $10.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Celularity | 30.75 Mn | 23.50 Mn | 3.09 Mn | 6.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.45 Mn |
| Mar 31, 2026 | 6.30 Mn |
| Dec 31, 2025 | 12.32 Mn |
| Sep 30, 2025 | 10.60 Mn |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 22.08 Mn |
| Dec 31, 2024 | 20.56 Mn |
| Sep 30, 2024 | 14.50 Mn |
| Jun 30, 2024 | 17.73 Mn |
| Mar 31, 2024 | 22.86 Mn |
| Dec 31, 2023 | 19.79 Mn |
| Sep 30, 2023 | 16.50 Mn |
| Jun 30, 2023 | 18.04 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 33.50 Mn |
| Sep 30, 2022 | 63.10 Mn |
| Jun 30, 2022 | 75.45 Mn |
| Mar 31, 2022 | 75.74 Mn |
| Dec 31, 2021 | 59.10 Mn |
| Sep 30, 2021 | 91.28 Mn |
API Access
Celularity Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();